Recent study results from Denmark showed an increase in melanoma incidence, and emphasized the importance of primary prevention in children and young adults and secondary prevention in older adults.
MRV Research
Recent Discovery Might Lead To Targeted Melanoma Therapies
A recent study published in the Molecular Cell journal explains how melanoma patients with higher levels of a specific protein have poorer survival outcomes.
Pembrolizumab vs. Chemo for Ipilimumab-Refractory Melanoma
Pembrolizumab has been shown to improve 6-month progression-free survival for patients with ipilimumab-refractory melanoma, according to a study published online ahead of print in The Lancet Oncology.
Researchers Investigate Novel Treatment for Metastatic Melanoma
A collaborative team of international researchers led by Dr. Howard L. Kaufman, MD, FACS, associate director for clinical science and chief surgical officer at Rutgers Cancer Institute of New Jersey, recently revealed a new investigational therapy with the potential to aid in the treatment of advanced-stage melanoma. The findings from the study, entitled, “Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma,”, were published in the Journal of Clinical Oncology.